Embedding routine health care data in clinical trials: with great power comes great responsibility.

IF 1.7 4区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Netherlands Heart Journal Pub Date : 2024-03-01 Epub Date: 2024-01-15 DOI:10.1007/s12471-023-01837-5
M Louis Handoko, Frances S de Man, Jasper J Brugts, Peter van der Meer, Hanneke F M Rhodius-Meester, Jeroen Schaap, H J Rik van de Kamp, Saskia Houterman, Dennis van Veghel, Alicia Uijl, Folkert W Asselbergs
{"title":"Embedding routine health care data in clinical trials: with great power comes great responsibility.","authors":"M Louis Handoko, Frances S de Man, Jasper J Brugts, Peter van der Meer, Hanneke F M Rhodius-Meester, Jeroen Schaap, H J Rik van de Kamp, Saskia Houterman, Dennis van Veghel, Alicia Uijl, Folkert W Asselbergs","doi":"10.1007/s12471-023-01837-5","DOIUrl":null,"url":null,"abstract":"<p><p>Randomised clinical trials (RCTs) are vital for medical progress. Unfortunately, 'traditional' RCTs are expensive and inherently slow. Moreover, their generalisability has been questioned. There is considerable overlap in routine health care data (RHCD) and trial-specific data. Therefore, integration of RHCD in an RCT has great potential, as it would reduce the effort and costs required to collect data, thereby overcoming some of the major downsides of a traditional RCT. However, use of RHCD comes with other challenges, such as privacy issues, as well as technical and practical barriers. Here, we give a current overview of related initiatives on national cardiovascular registries (Netherlands Heart Registration, Heart4Data), showcasing the interrelationships between and the relevance of the different registries for the practicing physician. We then discuss the benefits and limitations of RHCD use in the setting of a pragmatic RCT from a cardiovascular perspective, illustrated by a case study in heart failure.</p>","PeriodicalId":18952,"journal":{"name":"Netherlands Heart Journal","volume":" ","pages":"106-115"},"PeriodicalIF":1.7000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10884372/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Netherlands Heart Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12471-023-01837-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Randomised clinical trials (RCTs) are vital for medical progress. Unfortunately, 'traditional' RCTs are expensive and inherently slow. Moreover, their generalisability has been questioned. There is considerable overlap in routine health care data (RHCD) and trial-specific data. Therefore, integration of RHCD in an RCT has great potential, as it would reduce the effort and costs required to collect data, thereby overcoming some of the major downsides of a traditional RCT. However, use of RHCD comes with other challenges, such as privacy issues, as well as technical and practical barriers. Here, we give a current overview of related initiatives on national cardiovascular registries (Netherlands Heart Registration, Heart4Data), showcasing the interrelationships between and the relevance of the different registries for the practicing physician. We then discuss the benefits and limitations of RHCD use in the setting of a pragmatic RCT from a cardiovascular perspective, illustrated by a case study in heart failure.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
将常规医疗数据纳入临床试验:权力越大,责任越大。
随机临床试验(RCT)对医学进步至关重要。遗憾的是,"传统 "的 RCT 费用高昂,而且速度缓慢。此外,它们的普遍性也受到质疑。常规医疗保健数据(RHCD)与特定试验数据有相当大的重叠。因此,将 RHCD 纳入 RCT 具有很大的潜力,因为它可以减少收集数据所需的工作量和成本,从而克服传统 RCT 的一些主要缺点。然而,RHCD 的使用也面临其他挑战,如隐私问题以及技术和实际障碍。在此,我们将概述国家心血管登记处(荷兰心脏登记处、Heart4Data)的相关举措,展示不同登记处之间的相互关系以及对执业医师的意义。然后,我们从心血管角度出发,通过心力衰竭的案例研究,讨论了在务实的 RCT 环境中使用 RHCD 的好处和局限性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Netherlands Heart Journal
Netherlands Heart Journal CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
4.70
自引率
5.00%
发文量
84
审稿时长
6-12 weeks
期刊介绍: The scope of the Netherlands Heart Journal is to contribute to the national and international literature by publishing scientific papers in the field of cardiovascular medicine. It also provides a platform for Continuing Medical Education for cardiologists and those in training for the speciality of cardiology in the Netherlands. The Netherlands Heart Journal is made available to cardiologists, cardiologists in training, cardiopulmonary surgeons, cardiopulmonary surgeons in training, internists and paediatric cardiologists. The journal is the official journal of the Netherlands Society of Cardiology.
期刊最新文献
Cost-effectiveness of long term left ventricular assist devices. Reply to 'Cost-effectiveness of long term left ventricular assist devices'. The effects of spondylodiscitis on the inflammation burden in infective endocarditis. Growth rates in non-syndromic aneurysms of the ascending aorta: a systematic review. Advancing cardiovascular care-key insights from the Netherlands Heart Journal 2024.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1